Plano

True Stories

Liver disease kills nearly 3,000 Australians each year. Many of these deaths could be avoided, as the main causes of liver disease are treatable. Patients with liver disease are often from highly marginalised groups, specifically people who inject drugs and people on opioid substitution therapy. Strategies to enhance liver testing and treatment and targeted education are needed.

LiverLife is a Healthy Liver Campaign designed to bring awareness to liver testing and treatment and to help educate people about their liver. The initial phases of this study focus on developing and testing of the campaign messages and resources, which are designed to encourage people to maintain a healthy liver.

In the final study phase we will roll out the campaign at clinical sites. Participants will have access to a non-invasive liver test called a FibroScan®, they can discuss treatment options for liver disease with a specialist and they will receive tailored resources to help them learn more about their liver.

What is our key message?

A Healthy Liver Campaign can lead to an increase in knowledge of liver disease, increased uptake of liver assessment and an increased uptake of disease intervention and treatment.

Who is our target audience?

This study is run at participating opioid substitution treatment clinics in New South Wales, Australia. Adults aged > 18 years of age, with a history of injecting drug use are eligible to participate.

Who is involved?

This study is being conducted by the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Australia in collaboration with the:

  • Australian Injecting & Illicit Drug Users League
  • Centre for Health Initiatives, University of Wollongong
  • Centre for Social Research in Health, UNSW Australia
  • Hepatitis NSW
  • New South Wales Users and AIDS Association Inc.
  • St. Vincent?s Hospital, Sydney

Get involved

You can Get Involved or for more information, please Contact the research team.

True Stories